Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bush Medicare Proposal Would Require Price And Quality Transparency

This article was originally published in The Gray Sheet

Executive Summary

The Bush administration continues to push its priorities of value-based purchasing and price transparency for health care consumers through legislation aimed at saving the Medicare program from insolvency

You may also be interested in...

Budget Proposal Targeting Big Medicare Savings Could Inform Future Bill

The Bush administration's proposal to mine Medicare for massive cost savings has drawn a strong reaction from Democrats in Congress and device lobbyists. The budget request is unlikely to be adopted as proposed, but it could inform other Medicare legislation Congress has in the works

Administration Unveils Transparency Initiatives; Private Sector Follows Suit

The Bush Administration took several steps last week in its agenda for improving public access to price and quality information on healthcare procedures, and some private insurers have followed suit

Belgium Aims To Drive Biologic Competition Through Tendering

New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts